| GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism MA Mines, CJ Yuskaitis, MK King, E Beurel, RS Jope PloS one 5 (3), e9706, 2010 | 244 | 2010 |
| Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome CJ Yuskaitis, MA Mines, MK King, JD Sweatt, CA Miller, RS Jope Biochemical pharmacology 79 (4), 632-646, 2010 | 201 | 2010 |
| Glycogen synthase kinase-3 inhibitors: rescuers of cognitive impairments MK King, M Pardo, Y Cheng, K Downey, RS Jope, E Beurel Pharmacology & therapeutics 141 (1), 1-12, 2014 | 191 | 2014 |
| Updated report on tools to measure outcomes of clinical trials in fragile X syndrome DB Budimirovic, E Berry-Kravis, CA Erickson, SS Hall, D Hessl, AL Reiss, ... Journal of Neurodevelopmental Disorders 9, 1-36, 2017 | 134 | 2017 |
| Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice AV Franklin, MK King, V Palomo, A Martinez, LL McMahon, RS Jope Biological psychiatry 75 (3), 198-206, 2014 | 124 | 2014 |
| Psychological symptomatology following parental death in a predominantly minority sample of children and adolescents MP Thompson, NJ Kaslow, JB Kigree, M King, L Bryant, Jr, M Rey Journal of clinical child Psychology 27 (4), 434-441, 1998 | 90 | 1998 |
| Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome MK King, RS Jope Genes, Brain and Behavior 12 (7), 723-731, 2013 | 67 | 2013 |
| Learning-related diminution of unconditioned SCR and fMRI signal responses DC Knight, NS Waters, MK King, PA Bandettini Neuroimage 49 (1), 843-848, 2010 | 61 | 2010 |
| Social cognition, face processing, and oxytocin receptor single nucleotide polymorphisms in typically developing children MM Slane, LG Lusk, KB Boomer, AE Hare, MK King, DW Evans Developmental cognitive neuroscience 9, 160-171, 2014 | 37 | 2014 |
| Current applications and future trends in phased array technology X Gros, NB Cameron, M King Insight: The Journal of the British Institute of Non-Destructive Testing 44 …, 2002 | 27 | 2002 |
| Pain insensitivity: distal S6-segment mutations in NaV1.9 emerge as critical hotspot MK King, E Leipold, JM Goehringer, I Kurth, TD Challman Neurogenetics 18, 179-181, 2017 | 24 | 2017 |
| Improving autism and developmental screening and referral in US primary care practices serving Latinos KE Zuckerman, AE Chavez, L Wilson, K Unger, C Reuland, K Ramsey, ... Autism 25 (1), 288-299, 2021 | 19 | 2021 |
| Impairments in cognition and neural precursor cell proliferation in mice expressing constitutively active glycogen synthase kinase-3 M Pardo, MK King, E Perez-Costas, M Melendez-Ferro, A Martinez, ... Frontiers in behavioral neuroscience 9, 55, 2015 | 16 | 2015 |
| Parents' concerns are associated with early intervention evaluation and eligibility outcomes M Solgi, A Feryn, AE Chavez, L Wilson, M King, J Scholz, E Fombonne, ... Journal of Developmental & Behavioral Pediatrics 43 (3), e145-e152, 2022 | 9 | 2022 |
| Parent Concerns Are Associated With Early Intervention Outcomes A Feryn, AE Chavez, L Wilson, M King, J Scholz, E Fombonne, ... Portland State University, 2021 | | 2021 |
| Parent Concerns are Associated with Early Intervention Outcomes M Solgi | | 2021 |
| Contribution of hyperactive glycogen synthase kinase-3 (GSK3) to impaired neurogenesis and cognition in mice MK King | | 2014 |
| HOW DO COMMUNITY LIVING ADULTS OVER AGE 80 TYPICALLY PERFORM ON FUNCTIONAL MEASURES USED IN REHABILITATION? M Lusardi, K Chui, M King, C Carlin GERONTOLOGIST 48, 469-469, 2008 | | 2008 |
